MPO and pancreatic neoplasm: To investigate the contribution of neutrophils to the systemic LCN-2 pool in pancreatic cancer patients with and without cachexia, we quantified circulating levels of reliable neutrophil activation markers calprotectin, MPO, elastase, and BPI in relation to levels of LCN-2.